Dynavax Technologies Corporation
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes o…
Drug Manufacturers - Specialty & Generic
US, EmeryVille [HQ]
DVAX/Financial Reporting
Income Statements
Profit & Loss · 15 Statements · From 2023 to 2009Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.00 | 23.00 | 21.00 | 9.00 | 11.00 | 11.00 | 4.00 | 11.00 | - - | 8.00 | 35.00 | 46.00 | 439.00 | 722.00 | 232.00 | |
|
EPS
|
-7.57 | -6.95 | -3.88 | -4.10 | -3.40 | -3.45 | -3.25 | -2.92 | -1.81 | -2.55 | -2.10 | -0.91 | 0.62 | 2.32 | -0.05 | |
| Diluted in mil. | -7.57 | -6.95 | -3.88 | -4.10 | -3.40 | -3.45 | -3.25 | -2.92 | -1.81 | -2.55 | -2.10 | -0.91 | 0.54 | 1.97 | -0.05 | |
|
Profit
|
39.00 | 22.00 | 21.00 | 9.00 | 11.00 | 11.00 | 4.00 | 11.00 | - - | -13.00 | 15.00 | 32.00 | 265.00 | 460.00 | 182.00 | |
| Gross Margin | 97.57 | 95.91 | 98.62 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | -265.14 | -165.87 | 44.95 | 70.12 | 60.50 | 63.73 | 78.40 | |
| Pre Tax | -30.00 | -57.00 | -48.00 | -69.00 | -66.00 | -90.00 | -106.00 | -112.00 | -95.00 | -158.00 | -152.00 | -75.00 | 77.00 | 294.00 | -4.00 | |
| Profit Margin | -75.81 | -239.28 | -224.84 | -720.08 | -593.01 | -822.35 | -2,636.89 | -1,018.24 | -29,099.08 | -1,938.27 | -433.29 | -161.63 | 17.64 | 40.72 | -1.88 | |
| ETR | - - | -16.96 | -2.10 | -1.22 | 0.17 | 1.03 | 0.45 | 2.68 | -1.52 | -2.37 | 0.79 | -21.98 | 1.04 | 0.39 | -46.30 | |
| Net | -30.00 | -57.00 | -48.00 | -69.00 | -66.00 | -90.00 | -106.00 | -112.00 | -95.00 | -158.00 | -151.00 | -91.00 | 76.00 | 293.00 | -6.00 | |
| Profit Margin | -75.81 | -239.28 | -224.84 | -720.08 | -593.01 | -822.35 | -2,636.89 | -1,018.24 | -29,099.08 | -1,938.27 | -429.87 | -197.15 | 17.46 | 40.56 | -2.75 | |
| EBITDA | -12.00 | -37.00 | -46.00 | -67.00 | -65.00 | -90.00 | -104.00 | -110.00 | -89.00 | -149.00 | -114.00 | -67.00 | 142.00 | 298.00 | 20.00 | |
| EBITDA Margin | -30.45 | -154.67 | -216.57 | -695.88 | -579.16 | -822.04 | -2,581.51 | -1,002.51 | -27,292.05 | -1,824.36 | -325.87 | -144.26 | 32.38 | 41.27 | 9.03 | |
| Operating Income | -15.00 | -47.00 | -47.00 | -67.00 | -66.00 | -91.00 | -105.00 | -110.00 | -96.00 | -153.00 | -121.00 | -75.00 | 134.00 | 283.00 | -37.00 | |
| Operating Margin | -37.49 | -198.70 | -220.12 | -695.86 | -590.95 | -827.69 | -2,594.40 | -1,002.51 | -29,359.33 | -1,870.20 | -344.95 | -161.59 | 30.60 | 39.23 | -15.94 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 3.00 | 3.00 | 1.00 | - - | 7.00 | 31.00 | |
| Loss | -55.00 | -71.00 | -69.00 | -77.00 | -77.00 | -102.00 | -109.00 | -121.00 | -93.00 | -161.00 | -156.00 | -121.00 | -305.00 | -440.00 | -257.00 | |
| Cost of Revenue | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -21.00 | -19.00 | -13.00 | -173.00 | -262.00 | -50.00 | |
|
Operating Expenses
|
-55.00 | -71.00 | -69.00 | -77.00 | -77.00 | -102.00 | -109.00 | -121.00 | -93.00 | -139.00 | -137.00 | -107.00 | -132.00 | -178.00 | -207.00 | |
| R&D | -38.00 | -53.00 | -51.00 | -49.00 | -50.00 | -84.00 | -86.00 | -84.00 | -64.00 | -74.00 | -62.00 | -28.00 | -32.00 | -46.00 | -54.00 | |
| G&A | -15.00 | -16.00 | -17.00 | -28.00 | -26.00 | -17.00 | -22.00 | -37.00 | -27.00 | -64.00 | -48.00 | -79.00 | -100.00 | -131.00 | -152.00 | |
| SG&A | -15.00 | -16.00 | -17.00 | -28.00 | -26.00 | -17.00 | -22.00 | -37.00 | -27.00 | -64.00 | -74.00 | -79.00 | -100.00 | -131.00 | -152.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | -7.00 | -31.00 | -26.00 | -24.00 | - - | - - | - - | |
| Depreciation and Amortization | -2.00 | -2.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -2.00 | -4.00 | -14.00 | -21.00 | -9.00 | -7.00 | -6.00 | -7.00 | |
| Interest Expenses | - - | -1.00 | -1.00 | -2.00 | - - | - - | - - | - - | - - | -9.00 | -16.00 | -19.00 | -11.00 | -6.00 | -6.00 | |
| Other Expenses | -15.00 | -8.00 | - - | - - | - - | - - | -1.00 | -2.00 | -3.00 | - - | -31.00 | - - | -56.00 | -10.00 | -3.00 | |
|
WA Shares Outstanding
|
4.00 | 8.00 | 12.00 | 17.00 | 19.00 | 26.00 | 32.00 | 38.00 | 52.00 | 62.00 | 72.00 | 100.00 | 116.00 | 126.00 | 128.00 | |
| Diluted | 4.00 | 8.00 | 12.00 | 17.00 | 19.00 | 26.00 | 32.00 | 38.00 | 52.00 | 62.00 | 72.00 | 100.00 | 133.00 | 150.00 | 128.00 |